According to a market report published by Lucintel, the future of the optical imaging market looks promising with opportunities in the hospitals, diagnostic centers, and research laboratories. The optical imaging market is expected to grow with a CAGR of 12% from 2019 to 2024. The major growth drivers for this market are increasing prevalence of ophthalmological disorders, rise of noninvasive technologies, widening application areas of optical imaging technology, and growing need to minimize the use of radiation technologies.
To download report brochure, please go to https://www.lucintel.com/optical-imaging-market.aspx and click "report brochure" tab from the menu.
Optical imaging is the technique for taking images of the internal body parts non-invasively. Visible light and photons are used to take the detailed image of internal organs and tissues. In this market, optical coherence tomography (OCT), hyperspectral imaging (HSI), near-infrared spectroscopy (NIRS), photoacoustic tomography (PAT) are the major techniques. OCT is the largest market.
North America is expected to be the largest market over the forecast period due to high adoption rate of optical imaging devices and significant rise in technologies which made a positive impact in this region.
St. Jude Medical, Carl Zeiss Meditec, Bioptigen, Topcon, Canon, Headwall Photonics, Optovue, Perkinelmer, Koninklijke Philips and Agfa Healthcare are among the major manufacturers in the optical imaging market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the optical imaging market by technique, product, therapeutic area, application, end user, and region. Lucintel has prepared a comprehensive research report titled "Optical Imaging Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the optical imaging market by technique, product, therapeutic area, application, end user, and region as follows:
By Technique [$M shipment analysis for 2013 – 2024]:
Optical Coherence Tomography (OCT)
Hyperspectral Imaging (HSI)
Near-infrared Spectroscopy (NIRS)
Photoacoustic Tomography (PAT)
By Product [$M shipment analysis for 2013 – 2024]:
OCT Imaging System
Spectral Imaging System
PAT Imaging System
Diffuse Optical Tomography
Diffuse Optical Spectroscopy
Others
By Therapeutic Area [$M shipment analysis for 2013 – 2024]:
Ophthalmology
Neurology
Oncology
Dermatology
Others
By Application [$M shipment analysis for 2013 – 2024]:
Pathological Imaging
Intra-operative Imaging
Others
By End User [$M shipment analysis for 2013 – 2024]:
Hospitals and Clinics
Diagnostic Imaging Centers
Others
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
Asia Pacific
Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/optical-imaging-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.